To include your compound in the COVID-19 Resource Center, submit it here.

ADCendo licenses ADCs from University of Copenhagen

Newco ADCendo ApS (Copenhagen, Denmark) received exclusive, worldwide rights to antibody-drug conjugates (ADCs) targeting

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE